Roche Holding (SWX:ROG) reported highly positive Phase II results for its amylin analogue petrelintide in the ZUPREME-1 trial. The drug, co-developed with Zealand Pharma, achieved clinically ...

Lululemon trades at a decade-low 12x trailing earnings, with the market overly discounting Americas segment softness and ...

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced the appointment of interim leaders across its core business verticals ...